Sawgrass Asset Management’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-1,147
Closed -$287K 175
2020
Q4
$287K Sell
1,147
-162
-12% -$38.6K 0.02% 134
2020
Q3
$296K Sell
1,309
-1,251
-49% -$260K 0.02% 134
2020
Q2
$446K Sell
2,560
-65
-2% -$10.4K 0.03% 102
2020
Q1
$331K Buy
+2,625
New +$394K 0.03% 114
2019
Q2
Sell
-3,740
Closed -$543K 175
2019
Q1
$543K Buy
3,740
+475
+15% +$62.4K 0.02% 149
2018
Q4
$370K Buy
3,265
+365
+13% +$45.7K 0.02% 159
2018
Q3
$390K Hold
2,900
0.02% 175
2018
Q2
$326K Buy
2,900
+720
+33% +$77.8K 0.01% 193
2018
Q1
$233K Sell
2,180
-9,215
-81% -$993K 0.01% 195
2017
Q4
$1.25M Sell
11,395
-2,620
-19% -$285K 0.06% 113
2017
Q3
$1.51M Buy
14,015
+6,615
+89% +$680K 0.07% 87
2017
Q2
$749K Buy
+7,400
New +$681K 0.03% 115
2015
Q2
Sell
-3,850
Closed -$305K 122
2015
Q1
$305K Buy
+3,850
New +$284K 0.01% 103

Other funds holding CRL